VBIV logo

VBI Vaccines (VBIV) Operating Profit

VBIV Annual Operating Profit

-$55.31 M
+$26.51 M+32.40%

31 December 2023

VBIV Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBIV Quarterly Operating Profit

-$11.75 M
+$612.00 K+4.95%

31 March 2024

VBIV Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBIV TTM Operating Profit

-$47.56 M
+$7.76 M+14.02%

31 March 2024

VBIV TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VBIV Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.4%+30.8%+40.2%
3 y3 years-26.8%+45.2%+41.9%
5 y5 years+8.0%+45.2%+41.9%

VBIV Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time<-9999.0%<-9999.0%<-9999.0%

VBI Vaccines Operating Profit History

DateAnnualQuarterlyTTM
Mar 2024
-
-$11.75 M(-4.9%)
-$47.56 M(-14.0%)
Dec 2023
-$55.31 M(-32.4%)
-$12.36 M(+91.1%)
-$55.31 M(-14.1%)
Sept 2023
-
-$6.47 M(-61.9%)
-$64.39 M(-19.0%)
June 2023
-
-$16.97 M(-13.0%)
-$79.48 M(-6.9%)
Mar 2023
-
-$19.51 M(-9.0%)
-$85.41 M(+4.4%)
Dec 2022
-$81.82 M(+20.3%)
-$21.44 M(-0.6%)
-$81.82 M(+0.7%)
Sept 2022
-
-$21.56 M(-5.9%)
-$81.25 M(+8.7%)
June 2022
-
-$22.90 M(+43.9%)
-$74.72 M(+9.5%)
Mar 2022
-
-$15.92 M(-23.7%)
-$68.26 M(+0.3%)
Dec 2021
-$68.03 M(+56.0%)
-$20.87 M(+38.9%)
-$68.03 M(+10.9%)
Sept 2021
-
-$15.02 M(-8.6%)
-$61.37 M(+5.4%)
June 2021
-
-$16.44 M(+4.7%)
-$58.20 M(+16.6%)
Mar 2021
-
-$15.70 M(+10.4%)
-$49.90 M(+14.4%)
Dec 2020
-$43.62 M(-5.4%)
-$14.21 M(+19.9%)
-$43.62 M(+31.1%)
Sept 2020
-
-$11.85 M(+45.6%)
-$33.28 M(-11.4%)
June 2020
-
-$8.14 M(-13.5%)
-$37.57 M(-9.9%)
Mar 2020
-
-$9.41 M(+142.9%)
-$41.70 M(-9.6%)
Dec 2019
-$46.11 M(-23.3%)
-$3.88 M(-76.0%)
-$46.11 M(-23.7%)
Sept 2019
-
-$16.14 M(+31.6%)
-$60.46 M(+2.7%)
June 2019
-
-$12.27 M(-11.2%)
-$58.86 M(-5.6%)
Mar 2019
-
-$13.82 M(-24.2%)
-$62.33 M(+3.7%)
Dec 2018
-$60.13 M(+61.3%)
-$18.23 M(+25.4%)
-$60.13 M(+13.7%)
Sept 2018
-
-$14.54 M(-7.6%)
-$52.88 M(+11.4%)
June 2018
-
-$15.73 M(+35.4%)
-$47.48 M(+18.5%)
Mar 2018
-
-$11.62 M(+5.9%)
-$40.06 M(+7.4%)
Dec 2017
-$37.28 M(+50.0%)
-$10.98 M(+20.1%)
-$37.28 M(+6.6%)
Sept 2017
-
-$9.14 M(+10.0%)
-$34.97 M(+4.2%)
June 2017
-
-$8.31 M(-6.0%)
-$33.56 M(+7.8%)
Mar 2017
-
-$8.85 M(+2.1%)
-$31.13 M(+25.3%)
Dec 2016
-$24.85 M(+4.6%)
-$8.66 M(+12.0%)
-$24.85 M(-25.8%)
Sept 2016
-
-$7.74 M(+31.6%)
-$33.49 M(+14.4%)
June 2016
-
-$5.88 M(+129.5%)
-$29.26 M(+20.3%)
Mar 2016
-
-$2.56 M(-85.2%)
-$24.33 M(+8.6%)
Dec 2015
-$23.76 M(+474.3%)
-$17.30 M(+392.3%)
-$22.41 M(+244.6%)
Sept 2015
-
-$3.52 M(+270.8%)
-$6.50 M(+54.1%)
June 2015
-
-$948.00 K(+48.1%)
-$4.22 M(-1.1%)
Mar 2015
-
-$640.00 K(-54.2%)
-$4.27 M(-17.8%)
Mar 2015
-$4.14 M(-21.8%)
-
-
Dec 2014
-
-$1.40 M(+13.5%)
-$5.19 M(-10.6%)
Sept 2014
-
-$1.23 M(+24.0%)
-$5.80 M(+4.0%)
June 2014
-
-$994.00 K(-36.3%)
-$5.58 M(+4.7%)
Mar 2014
-$5.29 M(-28.3%)
-$1.56 M(-22.5%)
-$5.33 M(+19.3%)
Dec 2013
-
-$2.01 M(+99.1%)
-$4.47 M(+16.7%)
Sept 2013
-
-$1.01 M(+36.3%)
-$3.83 M(-34.3%)
June 2013
-
-$742.30 K(+6.4%)
-$5.82 M(-20.9%)
Mar 2013
-$7.38 M(-45.8%)
-$697.80 K(-49.3%)
-$7.36 M(-27.5%)
Dec 2012
-
-$1.38 M(-54.2%)
-$10.16 M(-12.6%)
Sept 2012
-
-$3.01 M(+32.0%)
-$11.62 M(-3.2%)
June 2012
-
-$2.28 M(-34.8%)
-$12.01 M(-12.8%)
Mar 2012
-$13.61 M(-46.3%)
-$3.49 M(+22.9%)
-$13.76 M(-52.0%)
Dec 2011
-
-$2.84 M(-16.1%)
-$28.65 M(+3.4%)
Sept 2011
-
-$3.39 M(-16.0%)
-$27.70 M(-0.6%)
June 2011
-
-$4.04 M(-78.0%)
-$27.87 M(+10.8%)
Mar 2011
-$25.33 M
-$18.38 M(+869.4%)
-$25.15 M(+250.8%)
Dec 2010
-
-$1.90 M(-46.7%)
-$7.17 M(+32.0%)
DateAnnualQuarterlyTTM
Sept 2010
-
-$3.55 M(+168.7%)
-$5.43 M(+177.2%)
June 2010
-
-$1.32 M(+232.9%)
-$1.96 M(+171.9%)
Mar 2010
-$731.60 K(+183.3%)
-$397.30 K(+150.7%)
-$720.80 K(+85.1%)
Dec 2009
-
-$158.50 K(+94.0%)
-$389.40 K(+31.9%)
Sept 2009
-
-$81.70 K(-1.9%)
-$295.20 K(-2.4%)
June 2009
-
-$83.30 K(+26.4%)
-$302.50 K(+8.2%)
Mar 2009
-$258.20 K(-55.2%)
-$65.90 K(+2.5%)
-$279.70 K(-17.8%)
Dec 2008
-
-$64.30 K(-27.8%)
-$340.20 K(-22.7%)
Sept 2008
-
-$89.00 K(+47.1%)
-$440.30 K(-20.2%)
June 2008
-
-$60.50 K(-52.1%)
-$551.60 K(-3.2%)
Mar 2008
-$576.00 K(+55.0%)
-$126.40 K(-23.1%)
-$569.70 K(-4.4%)
Dec 2007
-
-$164.40 K(-17.9%)
-$596.00 K(+20.6%)
Sept 2007
-
-$200.30 K(+154.8%)
-$494.00 K(+27.7%)
June 2007
-
-$78.60 K(-48.5%)
-$386.70 K(+2.2%)
Mar 2007
-$371.50 K(-10.4%)
-$152.70 K(+144.7%)
-$378.30 K(-26.5%)
Dec 2006
-
-$62.40 K(-32.9%)
-$514.70 K(+5.5%)
Sept 2006
-
-$93.00 K(+32.5%)
-$488.00 K(+10.3%)
June 2006
-
-$70.20 K(-75.7%)
-$442.40 K(+6.9%)
Mar 2006
-$414.70 K(+206.3%)
-$289.10 K(+709.8%)
-$414.00 K(+118.6%)
Dec 2005
-
-$35.70 K(-24.7%)
-$189.40 K(+11.0%)
Sept 2005
-
-$47.40 K(+13.4%)
-$170.70 K(+18.0%)
June 2005
-
-$41.80 K(-35.2%)
-$144.70 K(+16.5%)
Mar 2005
-$135.40 K(+2.5%)
-$64.50 K(+279.4%)
-$124.20 K(+48.9%)
Dec 2004
-
-$17.00 K(-20.6%)
-$83.40 K(-25.9%)
Sept 2004
-
-$21.40 K(+0.5%)
-$112.50 K(-7.2%)
June 2004
-
-$21.30 K(-10.1%)
-$121.20 K(-6.4%)
Mar 2004
-$132.10 K(+62.1%)
-$23.70 K(-48.6%)
-$129.50 K(-10.4%)
Dec 2003
-
-$46.10 K(+53.2%)
-$144.50 K(+34.3%)
Sept 2003
-
-$30.10 K(+1.7%)
-$107.60 K(+11.4%)
June 2003
-
-$29.60 K(-23.5%)
-$96.60 K(+24.3%)
Mar 2003
-$81.50 K(+15.8%)
-$38.70 K(+320.7%)
-$77.70 K(+12.6%)
Dec 2002
-
-$9200.00(-51.8%)
-$69.00 K(-3.2%)
Sept 2002
-
-$19.10 K(+78.5%)
-$71.30 K(+13.5%)
June 2002
-
-$10.70 K(-64.3%)
-$62.80 K(-11.9%)
Mar 2002
-$70.40 K(<-9900.0%)
-$30.00 K(+160.9%)
-$71.30 K(-363.1%)
Dec 2001
-
-$11.50 K(+8.5%)
$27.10 K(+67.3%)
Sept 2001
-
-$10.60 K(-44.8%)
$16.20 K(+376.5%)
June 2001
-
-$19.20 K(-128.1%)
$3400.00(-96.2%)
Mar 2001
$0.00(-100.0%)
$68.40 K(-405.4%)
$90.10 K(+311.4%)
Dec 2000
-
-$22.40 K(-4.3%)
$21.90 K(-80.7%)
Sept 2000
-
-$23.40 K(-134.7%)
$113.30 K(-17.1%)
June 2000
-
$67.50 K(>+9900.0%)
$136.70 K(-0.2%)
Mar 2000
-$68.80 K(-48.1%)
$200.00(-99.7%)
$137.00 K(+3086.0%)
Dec 1999
-
$69.00 K(>+9900.0%)
$4300.00(+1333.3%)
Sept 1999
-
$0.00(-100.0%)
$300.00(0.0%)
June 1999
-
$67.80 K(-151.2%)
$300.00(-50.0%)
Mar 1999
-$132.50 K(+88.2%)
-$132.50 K(-303.8%)
$600.00(-99.0%)
Dec 1998
-
$65.00 K(>+9900.0%)
$62.70 K(-7.2%)
Sept 1998
-
$0.00(-100.0%)
$67.60 K(-51.7%)
June 1998
-
$68.10 K(-196.7%)
$140.00 K(-3.0%)
Mar 1998
-$70.40 K(-2.9%)
-$70.40 K(-200.7%)
$144.30 K(-32.8%)
Dec 1997
-
$69.90 K(-3.5%)
$214.70 K(+48.3%)
Sept 1997
-
$72.40 K(0.0%)
$144.80 K(+100.0%)
June 1997
-
$72.40 K
$72.40 K
Mar 1997
-$72.50 K
-
-

FAQ

  • What is VBI Vaccines annual operaing income?
  • What is the all time high annual operating profit for VBI Vaccines?
  • What is VBI Vaccines annual operating profit year-on-year change?
  • What is VBI Vaccines quarterly operating income?
  • What is the all time high quarterly operating profit for VBI Vaccines?
  • What is VBI Vaccines quarterly operating profit year-on-year change?
  • What is VBI Vaccines TTM operating income?
  • What is the all time high TTM operating profit for VBI Vaccines?
  • What is VBI Vaccines TTM operating profit year-on-year change?

What is VBI Vaccines annual operaing income?

The current annual operating profit of VBIV is -$55.31 M

What is the all time high annual operating profit for VBI Vaccines?

VBI Vaccines all-time high annual operaing income is $0.00

What is VBI Vaccines annual operating profit year-on-year change?

Over the past year, VBIV annual operaing income has changed by +$26.51 M (+32.40%)

What is VBI Vaccines quarterly operating income?

The current quarterly operating profit of VBIV is -$11.75 M

What is the all time high quarterly operating profit for VBI Vaccines?

VBI Vaccines all-time high quarterly operating income is $72.40 K

What is VBI Vaccines quarterly operating profit year-on-year change?

Over the past year, VBIV quarterly operating income has changed by +$5.22 M (+30.76%)

What is VBI Vaccines TTM operating income?

The current TTM operating profit of VBIV is -$47.56 M

What is the all time high TTM operating profit for VBI Vaccines?

VBI Vaccines all-time high TTM operating income is $214.70 K

What is VBI Vaccines TTM operating profit year-on-year change?

Over the past year, VBIV TTM operating income has changed by +$31.92 M (+40.16%)